Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma

Human Gene Therapy

Volumn 8, Issue 7, 1997, Pages 875-891

  Mahvi, D M ^a   Sondel, P M ^a   Yang, N S ^a   Albertini, M R ^a   Hank, J ^a   Heiner, J ^a   Gan, J ^a   Swain, W ^a   Logrono, R ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLASMID VECTOR;

ANTINEOPLASTIC ACTIVITY; AUTOIMMUNITY; AUTOTRANSPLANTATION; CANCER IMMUNIZATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DNA TRANSFECTION; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MELANOMA; NONHUMAN; PATIENT MONITORING; PHASE 1 CLINICAL TRIAL; REVIEW; SOFT TISSUE SARCOMA; TUMOR CELL;

EID: 0030950724     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.7-875     Document Type: Review

References (49)

1. Berns AJ, Clift S, Cohen LK, Donehower RC, Dranoff G, Hauda KM, Jafee EM, Lazenby AJ, Levitsky HI, et al. Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum. Gene Ther. 6:347-368, 1995.
2. Mackiewicz A, Gorny A, Laciak M, Murawa P, Nowak J, Wiznerowicz M, Hawles RG, Heinrich PC, Rose-John S. Gene therapy of human melanoma. Immunization of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting interleukin 6 and soluble interleukin 6 receptor. Hum. Gene Ther. 6:805-811, 1995.
3. Freeman S, McCune C, Robinson W, Abboud C, Abraham G, Angel C, Marrogi A. The treatment of ovarian cancer with a gene modified cancer vaccine: A phase I study. Hum. Gene Ther. 6:927-939, 1995.
4. Cassileth P, Podack E, Sridhar K, Savaraj N. Phase I study of transfected cancer cells expressing the interleukin-2 gene product in limited stage small cell lung cancer. Hum. Gene Ther. 6:369-383, 1995.
5. Anderson WF. Hum. Gene Therapy. Science. 256:808-813, 1992.
6. Culver KW, Blaese RM. Gene therapy for cancer. Trends Genet. 10:174-178, 1994.
7. Plautz G, Nabel EG, Wu B, Gao X, Huang L, Nabel GJ. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. USA. 90:4645-4649, 1993.
8. Rosenberg SA, Anderson WF, Blaese M, Hwu P, Yanelli JR, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Ettinghausen SE, Parkinson DN, White DE. The development of gene therapy for the treatment of cancer. Ann. Surg. 218:455-464, 1993.
9. Dranoff GD, Mulligan RC. Gene transfer as cancer therapy. Adv. Immunol. 58:417-454, 1995.
10. Herrman F. Cancer gene therapy: Principles, problems, and perspectives. Clin. Invest. 73:157-163, 1995.
11. Ezzell G. Cancer "vaccines": An idea whose time has come? J. NIH Res 7:46-49, 1995.
12. Skolnick AA. 'Essential components now in place' for clinical testing of cancer vaccine strategies. JAMA. 273:528-530, 1995.
13. Koh HK. Cutaneous melanoma. N. Engl. J. Med. 325:171-182, 1991.
14. Friedman RJ, Rigel DS, Silverman MK, Kopf AW, Vossaert KA. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin. 41:201-226, 1991.
15. Diagnosis and treatment of early melanoma. NIH Consensus Development Conference, January 27-29, 1992. National Institutes of Health Consensus Statement, vol. 10, 1992.
16. Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, Bufalino R, Craig P, DeMarsillac J, Durand JC, van Geel AN, Holstrom H, Hunter JA, Jorgensen OG, Kiss B, Kroon B, Lacour J, Lejeune F, Mackie R, Mechl Z, Mitrov G, Morabito A, Nosek H, Panizzon R, Prade M, Santi P, Van Slooten E, Tomin R, Trapeznikov N, Tsanov T, Urist M, Wozniak KD. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N. Engl. J. Med. 318:1159-1162, 1988.
17. Guerry D, Schuchter LM. Disseminated melanoma - is there a new standard therapy? N. Engl. J. Med. 327:560-561, 1992.
18. Del Prete SA, Maurer LH, O'Donnell J, Forcier J, LeMarbre P. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer Treat. Rep. 68:1403-1405, 1984.
19. McClay EF, McClay MET. Tamoxifen: Is it useful in the treatment of patients with metastatic melanoma? J. Clin. Oncol. 12:617-626, 1994.
20. Ahmann DL, Creagan ET, Hahn RG, Edmonson JH, Bisel HF, Schaid DJ. Cancer. 63:224-227, 1989.
21. Balch CM, Houghton AN, Peters LJ. Cutaneous melanoma. In: Cancer: Principles and Practice of Oncology, 4th edition, VT DeVita Jr, S Hellman, SA Rosenberg, eds. Philadelphia: J.B. Lippincott, 1993, pp. 1612-1661.
22. Rosenberg SA, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA. 271:907-913, 1994.
23. Crowley NJ, Seigler HF. Possibilities of immunotherapy and gene therapy for malignant melanoma. Sem. Surg. Oncol. 9:273-278, 1993.
24. Hellman S. Immunotherapy for metastatic cancer establishing a "proof of principle." JAMA. 271:945-946, 1994.
25. Brichard V, Van Pel A, Wölfel T, Wölfel C, De Plaen E, Lethé B, Coulie P, Boon T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-195, 1993.
26. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA. 91:3515-3519, 1994.
27. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associate with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91:6458-6462, 1994.
28. Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft tissue sarcoma. Ann. Surg. 213:2-10, 1991.
29. Zalupski MM. Systemic adjuvant chemotherapy for soft-tissue sarcomas of the extremities. Surg. Oncol. Clin. N. Am. 2:621-637, 1993.
30. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony stimulating factors. Blood 67:35-43, 1987.
31. Munn DH, Garnick MB, Cheung NKV. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and anti-tumor cytotoxicity in nonhuman primates. Blood. 75:2042-2048, 1990.
32. Munn DH, Cheung NKV. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J. Exp. Med. 172:231-237, 1990.
33. Kleinerman ES, Knowles RD, Lachman LB, Gutterman JU. Effect of recombinant granulocyte/macrophage colony stimulating factor on human monocyte activity in vitro and following intravenous administration. Cancer Res. 48:2604-2609, 1988.
34. Grabstein KH, Urdal DL, Tushinski RJ, Mochizuki DY, Price VL, Cantrell MA, Gillis S, Conlon PJ. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor. Science. 232:506-508, 1986.
35. Thomassen MJ, Ahmad M, Barna BP, Antal J, Wiedemann HP, Meeker DP, Klein J, Bauer L, Gibson V, Andresen S, Bukowski RM. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony stimulating factor therapy. Cancer Res. 51:857-862, 1991.
36. Morrissey PJ, Bressler L, Charrier K, Alpert A. Response of resident murine peritoneal macrophages to in vivo administration of granulocyte macrophage colony stimulating factor. J. Immunol. 140:1910-1915, 1988.
37. Bausero MA, Panoskaltsis-Mortari A, Zu Z, Blazar BR, Katsanis E. Effect immunization against murine neuroblastoma using transduced tumor cells secreting GM-CSF and Interferon. Cancer Gene Ther. 2:309, 1995.
38. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, and Mulligan R. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90:3539-3543, 1993.
39. Sun WH, Burkholder JK, Sun J, Culp J, Turner J, Lu XG, Pugh TD, Ershler WB, Yang N-S. In vivo cytokine gene transfer by gene gun suppresses tumor growth in mice. Proc. Natl. Acad. Sci. USA. 87:9568-9572, 1995.
40. Crystal RG. Transfer of genes to humans: Early lessons and obstacles to success. Science. 270:404-410, 1995.
41. McCabe D, Swain W, Martinell B, Christou P. Stable transformation of soybean (glycine max) by particle acceleration. Biotechnology. 6:923-926, 1988.
42. McCabe D, Martinell B. Apparatus for genetic transformation. Patent #US 5149655, 1992.
43. Yang N-S, Burkholder J, Roberts B, Martinell B, McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment Proc. Natl. Acad. Sci. USA. 87:9568-9572, 1988.
44. Thompson TA, Gould MN, Burkholder JK, Yang N-S. Transient promoter activity in primary rat mammary epithelial cells evaluated using particle bombardment gene transfer. In Vitro Cell Dev. Biol. 29A:165-170, 1993.
45. Yang, N-S, and Sun, WH. Gene gun and other non-viral approaches for cancer gene therapy. Nat. Med. 1:481-483, 1995.
46. Pertmer TM, Eisenbraun MD, McCabe D, Prayaga SK, Fuller DH, and Haynes JR. Gene gun based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine. 1996, in press.
47. Cheng L, Ziegelhoffer P, and Yang N-S. In vitro promoter activity and transgene expression mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA. 90:4455-4459, 1993.
48. Burkholder JK, Decker J, and Yang N-S. Rapid transgene expression in lymphocyte and macrophage primary cultures after particle-bombardment mediated gene transfer. J. Immunol. Methods. 165:149-156, 1993.
49. Jiao S, Cheng L, Wolff JA, Yang N-S. Particle bombardment-mediated gene transfer and expression in rat brain tissues. Biotechnology. 11:497-502, 1993.